Skip to content
Sunday, November 8, 2026
Discover expert tips, deck builds, and strategies for Clash…

Academic Said to Have Stopped UK Puberty Blockers Study Recused Due to Partiality Allegations

A high-ranking health officer was removed of oversight in a key research project into puberty blockers following claims regarding preconceived views surfaced.

Alleged Involvement Led to Trial Pause

As reported by news reports, Professor Jacob George, a head medical and scientific officer for the MHRA, raised issues that resulted in the pausing of a government-backed clinical study in the winter.

The regulator stated this weekend how the professor was recusing him from any role with the trial after questioning social media remarks posted last year came to light.

Nature Regarding the Online Comments

In one statement, George referred to author the Harry Potter author being a valuable figure of our time.” In another, the professor stated that the refusal to accept basic biological fact was concerning” in regards to debates about a Olympic boxer’s sex.

This agency said that while the comments were made before the appointment, the official was removed of involvement in the trial as an abundance of caution.

Particulars Regarding the Halted Clinical Study

This Pathways trial, which aimed to assess the influence of puberty blockers for adolescents questioning their own gender, was due to start enrolling participants during the start of the year.

However, the trial was paused during the following month when its agency raised concerns about the welfare of young participants participating.

  • Its most junior volunteers were anticipated to be 10 to 11 among assigned female at birth and 11 to 12 for biological males.
  • The trial leadership stated previously how the thorough screening procedure indicated those enrolled would likely be more mature.
  • But, the regulator has now said the lowest age requirement ought to be fourteen owing to an unknown danger” for enduring physical side effects.”

This clinical trial aimed to enroll a projected two hundred and twenty-six youths during the next several years.

Background Following a Cass Review

The trial was announced subsequent to a suggestion by the Cass review into children’s gender identity services, that found that the robustness of research suggesting to prove the benefits from such drugs in children experiencing gender dysphoria were “poor.”

Dr Hilary Cass, who chaired that inquiry, has previously said the report “uncovered a very weak evidence base” for the benefits of puberty blockers.

She noted, “given that there are medical professionals, young people and parents who are convinced strongly of the helpful results, a trial was the necessary step forward to clarify the situation.”

Expert Concern of the Action

Dr Max Davie, a consultant paediatrician, stated there was no strong medical rationale to suspend the research.

“The social media posts from Professor George give an obvious insight of his own opinions on this issue,” he stated. “The professor is free to possess any beliefs on this subject he wishes, however what is unacceptable is allow these beliefs to impact the performance of his official role.”

The doctor added: “To be clear, there is no compelling medical basis to halt this study. Although the professor’s own views are not the sole potential reason for the MHRA’s unexpected change of position, it is the single factor for which we have evidence.”

Regulator Statement and Future Actions

An MHRA representative commented: “With all medical studies, the MHRA’s top priority is the protection and welfare of the volunteers. As part of that commitment, detailed studies are kept continuously under scrutiny while the MHRA keeps an ongoing conversation alongside research organizers.”

“The MHRA have world-class medical, scientific and regulatory experts who function as a collaborative group to deliver evidence-based rulings regarding medical research. These individuals shall persist to work alongside the research team to navigate the next steps productively.”

“Subsequent to the finding regarding online posts made prior to his appointment, Prof Jacob George is recused from continued participation with the Pathways study as an abundance of caution.”

Written by

Lisa Jones

A seasoned gamer and strategy expert with over a decade of experience in competitive gaming and content creation.

Clash Masters

Type to search articles.